FOIA document: In 2007, US Ambassador Ralph Boyce was pleased that Abbott withdrew life saving drugs from market in ThailandSubmitted by James Love on 6. March 2010 - 17:26
In 2007, Thailand was involved in a dispute over the granting of compulsory licenses on medicines, including the patents used for Kaletra, an Abbott drug used in the treatment of AIDS. Kaletra is the brand name for a fixed dose combination of lopinavir and ritonavir (LPV/r) -- two drugs invented at Abbott on an NIH grant. In 2007, LPV/r was the preferred combination for protease inhibitor regimes used to treat AIDS.
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.
Select Joint Ventures, Partnerships, and Alliances with Big Pharma
Abbott and Millennium - In March 2001 Abbott and Millennium formed a strategic alliance for the discovery, development and commercialization of drugs and diagnostics in the area of obesity and diabetes. This alliance also provided for non-exclusive technology transfer and the co-development of technology tools. According to Millennium's 2001 SEC filing, the deal i
R 131556Z – October 13, 2005
FM AMEMBASSY BRAZILIA
TO SECSTATE WASHDC 3176
SUBJECT: ABBOTT AND GOB REACH DEAL TO AVOID COMPULSORY LICENSE
1. SENSITIVE BUT UNCLASSIFIED – PLEASE TREAT ACCORDINGLY